Can numbness in hands, feet, and head be a side effect of clonazepam (Klonopin), escitalopram (Lexapro), and hydroxyzine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medication-Induced Numbness Assessment

Numbness in the hands, feet, and head is unlikely to be a direct side effect of clonazepam, escitalopram (Lexapro), or hydroxyzine, as these medications are not typically associated with peripheral neuropathy or sensory disturbances in these distributions. This symptom pattern warrants evaluation for alternative causes rather than attributing it to the current medication regimen.

Why These Medications Are Unlikely Culprits

Clonazepam (Klonopin)

  • Common side effects include morning sedation, motor incoordination, confusion, and memory dysfunction—not numbness or paresthesias 1
  • Clonazepam is actually used therapeutically to treat certain movement disorders and tremor, not known to cause sensory neuropathy 2
  • Withdrawal symptoms from clonazepam include anxiety, tremor, sweating, and muscle aches—but not numbness 3

Escitalopram (Lexapro)

  • SSRIs like escitalopram can cause movement disorders such as akathisia (restlessness) and tremor, but numbness is not a recognized adverse effect 4, 5
  • Neonatal studies show SSRI effects include irritability, tremors, and feeding difficulties—not sensory neuropathy 6
  • Drug-induced tremor from SSRIs is well-documented, but peripheral sensory symptoms are not 5

Hydroxyzine

  • Reported adverse effects include tremors, irritability, hyperactivity, and feeding problems in neonatal withdrawal studies—not numbness or paresthesias 6
  • This antihistamine primarily causes sedation and anticholinergic effects, not neuropathic symptoms

What to Evaluate Instead

Peripheral Neuropathy Assessment

  • Ask specifically about the characteristics: Is it constant or intermittent? Does it follow a "glove and stocking" distribution? Is there associated pain, tingling, or burning? 6
  • Assess for numbness and tingling in hands and feet as distinct from head involvement, which suggests a different etiology 6
  • The combination of extremity and head numbness is atypical for common peripheral neuropathies and raises concern for other causes 7

Alternative Causes to Consider

  • Vitamin B12 deficiency (can cause peripheral neuropathy with paresthesias)
  • Diabetes or prediabetes (diabetic neuropathy presents with glove-and-stocking distribution) 6
  • Thyroid dysfunction (hypothyroidism can cause paresthesias)
  • Cervical spine pathology (can cause upper extremity and head symptoms)
  • Anxiety/hyperventilation (can cause perioral and extremity numbness—important given the patient is on anxiolytics)
  • Autoimmune conditions (lupus, rheumatoid arthritis can cause neuropathy) 7

Clinical Pitfalls to Avoid

Do not automatically attribute new neurological symptoms to psychiatric medications without proper workup. While it may be tempting to blame the medications, this can delay diagnosis of serious underlying conditions.

The head numbness is particularly concerning and atypical for medication side effects—this distribution suggests either:

  • Anxiety-related hyperventilation syndrome (perioral and extremity paresthesias)
  • Central nervous system pathology
  • Migraine-associated symptoms
  • Functional neurological disorder

Recommended Action Plan

  1. Obtain basic laboratory studies: complete blood count, comprehensive metabolic panel, vitamin B12, folate, thyroid function, hemoglobin A1c 6, 7

  2. Perform a focused neurological examination checking for objective sensory deficits, reflexes, and motor strength 6

  3. Consider whether anxiety or panic symptoms could be causing hyperventilation-related paresthesias—this is particularly relevant given the patient's medication regimen suggests underlying anxiety disorder

  4. If objective neuropathy is confirmed, consider duloxetine as it treats both neuropathic pain and anxiety/depression 6

  5. Do not discontinue the current medications without identifying an alternative cause, as abrupt benzodiazepine discontinuation can cause serious withdrawal symptoms 3

References

Guideline

Clonazepam's Impact on Restorative Sleep

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Agent Orange and Peripheral Neuropathy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.